Search results
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 4 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 4 days agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 6 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 5 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 6 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 19 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoBlueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript May 2, 2024 Blueprint...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 19 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Earnings call: GSK forecasts growth with strong Q1 performance
Investing.com· 1 day agoGSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...
'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse
The Day· 3 days agoThe American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...